Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHEN J DESPINS

Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation

NPI
1366974487
CMS profile
9920183
Location
LYNCHBURG, VA

General Payments · PY2022–2024

$500.69

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$355.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $355.31 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $71.00 3
ITI, Inc. $69.06 3
Lilly USA, LLC $58.53 3
DEXCOM, INC. $41.75 2
Xeris Pharmaceuticals, Inc. $37.11 2
Bioventus LLC $27.17 1
Neurocrine BioSciences, Inc. $27.09 1
Novo Nordisk AS $23.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $25.06 1
PY2023 $120.32 6
PY2024 $355.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.93 04/17/2024 Food and Beverage Undisputed 01/23/2026 1103630560 CMS
ABBVIE INC. $32.09 08/15/2024 Food and Beverage Undisputed 01/23/2026 1103630562 CMS
ABBVIE INC. $23.98 09/09/2024 Food and Beverage Undisputed 01/23/2026 1103630564 CMS
Bioventus LLC $27.17 07/03/2024 Food and Beverage Undisputed 01/23/2026 1137439239 CMS
Dexcom, Inc. $20.68 01/08/2024 Food and Beverage Undisputed 01/23/2026 1153338299 CMS
Dexcom, Inc. $21.07 05/13/2024 Food and Beverage Undisputed 01/23/2026 1153338301 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.48 02/05/2024 Food and Beverage Undisputed 01/23/2026 1143216192 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.84 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143216196 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.74 07/30/2024 Food and Beverage Undisputed 01/23/2026 1143216200 CMS
Lilly USA, LLC $15.74 04/09/2024 Food and Beverage Undisputed 01/23/2026 1135387969 CMS
Lilly USA, LLC $24.63 05/11/2024 Food and Beverage Undisputed 01/23/2026 1135427004 CMS
Lilly USA, LLC $18.16 09/26/2024 Food and Beverage Undisputed 01/23/2026 1135350296 CMS
Neurocrine Biosciences, Inc. $27.09 05/28/2024 Food and Beverage Undisputed 01/23/2026 1150833488 CMS
Novo Nordisk Inc $23.60 09/10/2024 Food and Beverage Undisputed 01/23/2026 1096628113 CMS
Xeris Pharmaceuticals, Inc. $17.16 01/15/2024 Food and Beverage Undisputed 01/23/2026 1144614451 CMS
Xeris Pharmaceuticals, Inc. $19.95 03/25/2024 Food and Beverage Undisputed 01/23/2026 1144614453 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.